ADVERTISEMENT
Episode 4: Industry Standards Needed for Next-Generation Sequencing in Cancer Care
On episode 4 of Oncology Innovations, host Gordon Kuntz sits down with Ira Klein, MD, MBA, of Tempus Labs, to discuss the need for industry standards in next-generation sequencing (NGS) and comprehensive genomic profiling (CGP). Gordon and Dr Klein address how the lack of standards is hurting patients and providers in terms of access and administrative waste and is hurting payers in subverting care to wasteful therapies and curving use of clinical trials.
Catch up with more episodes of Oncology Innovations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement